Company Number: 13970920

Analysis Date: 2025-07-29 19:49 UTC

1. Risk Rating: LOW
   The company demonstrates a solid liquidity position with current assets significantly exceeding current liabilities and positive net current assets. It has no overdue filings or indications of regulatory non-compliance. The business is small-scale and relatively new but appears to be financially stable without evidence of distress.

2. Key Concerns:

• Limited scale and short operating history (incorporated March 2022) restrict the ability to assess long-term operational sustainability.
• Minimal share capital (£2.00) may limit capacity to absorb losses or raise capital quickly if needed.
• The company operates with only one employee (the director), which could present operational risk if key personnel become unavailable.

3. Positive Indicators:

• Strong liquidity indicated by cash balances (£39,452) well above short-term liabilities (£5,844) as of March 2024.
• Positive and growing net current assets and shareholders’ funds (increased from £23,593 in 2023 to £35,984 in 2024).
• No overdue statutory filings and compliance with Companies House requirements, reducing regulatory risk.
• The company operates in a specialised medical practice sector (SIC 86220), which generally enjoys stable demand.

4. Due Diligence Notes:

• Verify the nature and sustainability of revenue streams as turnover and profit details are not disclosed in the accounts.
• Confirm the adequacy of internal controls and business continuity plans given the sole employee/director structure.
• Review any contingent liabilities or off-balance sheet obligations not disclosed in the available accounts.
• Investigate the background and reputation of the director and persons with significant control for any undisclosed risks.